Osteosarcoma: a review of 50 patients treated at the University of Alabama in Birmingham Medical Center between 1944 and 1975.
Only 12% of 50 patients lived 5 years or longer. Those who survived the longest were those with the tumor in the distal part of the lower extremity, with a well differentiated or chondroblastic tumor, or those who underwent radical surgery. Patients treated with surgery and chemotherapy lived about 1.5 months longer than those treated with sugery alone and about 1.2 months longer than those who had radiation included in the therapy. For a patient with a diagnosis of osteosarcoma, the prognosis was to be grave, no matter which methods of treatment were used.
D000293:Adolescent; D000328:Adult; D000407:Alabama; D044383:Black People; D001859:Bone Neoplasms; D002648:Child; D005260:Female; D005266:Femoral Neoplasms; D005360:Fibula; D006801:Humans; D006811:Humerus; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D012516:Osteosarcoma / Q000401:mortality / Q000628:therapy; D011247:Pregnancy; D011248:Pregnancy Complications; D012737:Sex Factors; D013977:Tibia; D001741:Black or African American